U.S. stock futures traded higher after President Donald Trump issued positive remarks on the U.S.-China trade talks.Marketsread more
SAP said on Thursday that Bill McDermott is stepping down as CEO. Board members Jennifer Morgan and Christian Klein have been appointed co-CEOs.Technologyread more
For investors reading the tea leaves of every trade headline, watch these stocks as they will tell you first if any progress is made.Marketsread more
Apple has been playing a careful game of politics with China for the last few years. China is one of the company's most important markets.Technologyread more
NBA players understand the economic consequences of speaking out on political issues, former All-Star Jamal Mashburn tells CNBC.Sportsread more
The number of fatalities jumped from 18 last week to 26 with 219 new cases diagnosed over the last week, the CDC said.Health and Scienceread more
A House panel is requesting a slew of documents from Reynolds after the company ignored the committee's request to stop advertising its e-cigarettes.Health and Scienceread more
Trump said he's meeting with Liu He on Friday, fueling optimism about a positive outcome from this week's high-level trade talks.Marketsread more
Jim Cramer of "Mad Money" walks investors through his rubric for "what's worth buying in this treacherous moment."Mad Money with Jim Cramerread more
Walmart said Thursday that its president and CEO in the U.S., Greg Foran, is stepping down, to be replaced by the head of its wholesale Sam's Club business, John Furner.Retailread more
Researchers from the Aspen Institute are raising concerns about a Florida initiative meant to collect and collate huge swaths of data on schoolchildren in the state, according...Technologyread more
When it comes to IPOs, sex may sell better than the internet, with shares of the world's largest condom maker popping more than 30 percent on their debut, while Twitter's offering faces an uncertain reception.
Karex, which has around 10 percent of the global condom market, saw its shares surge as high as 2.50 Malaysian ringgit, or around $0.79, on its Malaysian debut, up from its 1.85 ringgit offering price. The stock closed at 2.45 ringgit.
Meanwhile,Twitter's trading debut, set for Thursday, is facing some skepticism among analysts who are worried it may suffer the same fate as social media peer Facebook's ill-starred IPO last year. That IPO not only failed to pop on its first day, but proceeded to lose more than half its value over the next four months.
An AP-CNBC poll showed nearly half of active investors felt twitter's IPO wouldn't be a good investment.
(Read more: Big global challenge: Men don't like condoms)
When it comes to the condom industry, Karex is the biggest of the big. The company, which makes Durex and LifeStyles brand condoms under contract, is planning to use its IPO proceeds of around 75 million ringgit ($23.5 million) to double its annual capacity to around six billion pieces by the end of 2015, said Lee Yen Ling, an analyst at Maybank, in a report subtitled "rising to the occasion."
She set a fair value of 2.16 ringgit for the stock, citing "tremendous growth opportunities."
Karex's next largest competitor, Thai Nippon Rubber, can produce around 2 billion pieces a year.
"There is a shortage of condom supply in the market, as reported by the various NGOs and government agencies," Lee said. "The other condom manufacturers are not committed in expanding their capacities," she added, forecasting Karex's market share to rise to 15 percent by 2015.
(Read more: Condoms inPorn? Just Another Day at Wicked Pictures)
Analysts at another bank, RHB, are also positive on the stock, initiating it at "Buy" with a 2.59 ringgit target price, citing Infobusiness Research's forecasts for the global condom market to grow to 30.4 billion pieces a year by 2016, compared with 21.2 billion in 2011.
"We believe that the consumption of condoms will rise in tandem with the growing world population, which is currently increasing by 1 billion people every 12 years and is expected to reach 8.1 billion by 2025," RHB said.
"Growing health awareness in developing countries of the need for family planning as well as the prevention of the spread of HIV and various sexually transmitted infections (STIs) will also help boost condom demand," it added. "Given that the usage of condoms in China is still growing from a low base, we see huge potential for condom sales growth in the commercial market."
(Read more: Zurich 'sex boxes' hailed a success
In addition to its commercial clients and its own brand Carex, the company makes condoms for the institutional market, including the United Nations Population Fund (UNFPA) and United States Agency for International Development (USAID), RHB noted.
Karex's condoms are pre-qualified to meet the industry's stringent standards in 110 countries, offering a key competitive advantage against any Johnny-come-lately competitors who will need to go through the high cost and time of obtaining new accreditation, RHB noted.
—By CNBC's Leslie Shaffer; Follow her on twitter